Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Elsie

Elsie Gaite, Wauconda, IL US

Patent application numberDescriptionPublished
20100196541Frozen Sheeted Icing Formulation - A frozen sheeted icing comprising 2 to 10% by weight water; 10-30% by weight fat; 60-75% by weight sweetener solids; and 0.2 to 5.2% by weight of one or more gums. The composition can be prepared by mixing the ingredients to form an icing composition. The composition is then sheeted into desired shape, size and thickness. The sheeted icing is frozen and can be stored in the freezer until use. Also a method for icing a food product comprising the steps of providing a frozen sheet of icing; disposing the frozen sheet of icing on a surface of the food product; and exposing the disposed frozen sheet of icing to a temperature such that the frozen sheet of icing becomes sufficiently pliable and conforms or can be conformed to a surface of the food product. This results in forming an icing layer on the desired surfaces of the food product.08-05-2010

Elsie Melsopp, Wilmington, NC US

Patent application numberDescriptionPublished
20100159001Extended-Release Pharmaceutical Formulations - The present invention provides matrix-forming, sustained-release pharmaceutical formulations comprising four primary components: i) an effective amount of at least one drug substance; ii) at least one pharmaceutically acceptable, water-swellable, pH independent polymer; iii) at least one pharmaceutically-acceptable, anionic, pH dependent polymer; and (iv) a pharmaceutically-acceptable polymer selected from the group consisting of a) at least one pharmaceutically-acceptable cationic polymer; and b) at least one pharmaceutically acceptable hydrocolloid. The present formulations can be used with compounds having a wide range of solubilities as well as compounds characterized as having hydrophobic or hydrophilic characteristics.06-24-2010
20100160363EXTENDED-RELEASE PHARMACEUTICAL FORMULATIONS - The present invention provides matrix-forming, sustained-release pharmaceutical formulations comprising four primary components: i) an effective amount of at least one drug substance; ii) at least one pharmaceutically acceptable, water-swellable, pH independent polymer; iii) at least one pharmaceutically-acceptable, anionic, pH dependent polymer; and (iv) a pharmaceutically-acceptable polymer selected from the group consisting of a) at least one pharmaceutically-acceptable cationic polymer; and b) at least one pharmaceutically acceptable hydrocolloid. The present formulations can be used with compounds having a wide range of solubilities as well as compounds characterized as having hydrophobic or hydrophilic characteristics.06-24-2010

Elsie Van Herrewegen, Horgen CH

Patent application numberDescriptionPublished
20090313474NON-TRANSFERABLE ANONYMOUS DIGITAL RECEIPTS - The present invention relates electronic receipts. There is provided a method for generating an electronic receipt in a communication system providing a public key infrastructure, the method comprising the steps of receiving by a second party a request message from a first party, the request message comprising a transaction request and a first public key based on a secret owned by the first party and wherein the secret is associated with at least the secret of a further public key of the first party, electronically signing at least part of the request message with a second public key assigned to the second party to issue the electronic receipt, and providing the electronic receipt to the first party. Further, there is provided a method for verifying the ownership of an electronic receipt in a communication system providing a public key infrastructure, the verification arising out of a series of messages being sent and received between a first party and a verifying party, the method comprising the steps of receiving a proof message from the first party, the proof message being derived from at least a first public key based on a secret owned by the first party and wherein the secret is associated with at least the secret of a further public key of the first party and an electronic receipt that has been issued by electronically signing a request message with a second public key, determining whether or not the proof message was derived from the second public key.12-17-2009